Orozco-Gutiérrez AK, Ávila-Iglesias MC

Language: Spanish
References: 18
Page: 87-92
PDF size: 263.38 Kb.

ABSTRACT

Transient neonatal myeloproliferative disorder (TMD) is an hematological condition characterized by an abnormal clonal proliferation of myeloid blasts in peripheral blood. 10% of Down´s syndrome newborns develop this blood alteration. Myeloproliferative disorder remits within the first six moths of life in 80% of the patients. Most of reported cases have only required supportive therapy. However in 17% of this individuals the first clinical manifestations are life threatening disorders such as hepatic failure, or hemodynamic and respiratory disfunction, in these circumstances chemotherapy is indicated. TMD cannot be considered a benign disease since these patients are at a great risk to develop acute megacaryoblastic leukemia within the first 5 years of life. We present two patients with TMD who had a favourable course; both normalized the number of blast cells in peripheral blood while being monitored in a neonatal intensive care unit. Chemotherapy was not required. Management was limited to supportive measures are being followed as external patients.

REFERENCES

1. Klaussman J, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, Pekrun A, Macakova-Reinhardt K, Reinhardt D. Treatment and prognostic impact of transient leukemia in newborns with Down syndrome. Blood 2008;111(6):2991-8.

2. De Tar M, Dittman W, Gilbert J. Transient myeloproliferative disease of the newborn: case report with placental cytogenetic and flow cytometric findings. Human Pathol 2000;31:396-8.

3. Karandikar N, Aquino D, McKenna R, Kroft S. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. Am J Clin Pathol 2001;116:204-10.

4. Zipursky A. Transient leukaemia: a benign form of leukaemia in newborn infants with trisomy 21. Br J Haematol 2003;120:930-8.

5. Massey G, Zipursky A, Chang M, Doyle J, Nasim S, Taub J, Rivandranath Y, Dahi G, Weinstein H. A prospective study of the natural history of transient leukemia in neonates with Down syndrome: Children´s Oncology Group study. POG-9481. Blood 2006;107:4606-13.

6. Dormann S, Krüger M, Hentschel R, Rasennack R, Strahm B, Kontny U, Neimeyer Ch. Life threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome. Eur J Pediatr 2004;163:374-7.

7. Whitlock J, Sather HN, Gaynon P, Robinson LL, Wells R, Heerema NA,Bhatia S. Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a children´s cancer group study. Blood 2005;106:4043-9.

8. Pine Sh, Guo Q, Yin Ch, Jayabose S, Druschel Ch, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood 2007;110:2128-31.

9. Hayashi Y. Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome. Leukemia 2002;16:1866-7.

10. Girodon F, Favre B, Couillaud G, Carli P, Parmeland Ch, Maynadié M. Immunophenotype of a transient myeloproliferative disorder in a newborn with trisomy 21. Cytometry 2000;42:118-22.

11. de Rubens J, del Pozo B,Pablos J,Calderón C,Castrejón R. Malformaciones cardiacas en los niños con síndrome de Down. Rev Esp Cardiol 2003;9:894-9.

12. Bloemers BL, Van Bleek GM,Kimpen JL, Bont L. Abnormalities in the innate system of children with Down syndrome. J. Pediatr 2010;5:804-9.

13. Niramis R, Anuntkosol M,Tongsin A, Mahatharadol V. J Pediatr Surg 2010;45:1467-72.

14. Rabin K, Whitlock J. Malignancy in children with trisomy 21. Oncologist 2009;14:164-73.

15. Loft IT, Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down´s syndrome. Lancet Neurol 2010;6:623-33.

16. Bastida P, Oliveras O, Díaz de Heredia G, Ortega J. Síndrome mieloproliferativo transitorio neonatal en ausencia de síndrome de Down. An Pediatr 2004;6:546-50.

17. Brissette M, Duval-Arnould B, Gordon B, Cotelingam J. American Journal of Hematology 1994;47:316-9.

18. Ridgway D, Benda G, Magenis E, Leland A, Segal G, Braziel R,Neerhout R. Transient myeloproliferative disorder of the Down type in the normal newborn. AJDC 1990;144:1117-9.